Patent · US Expired

Vaccine against Lyme disease

US6613331B1 · kind B1 · utility

9Cited by

4References

5Claims

0Family size

Assignees

Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS · DE

Inventors

Markus Simon · Buckenhof, DE
Ulrich E. Schaible · Freiberg, DE
Klaus Eichmann · Glückstadt, DE
Michael Kramer · Freiberg, DE
Wallich Reinhard · Heidelberg, DE

Key dates

Filing date	Oct 7, 1999
Grant date	Sep 2, 2003
Priority date	—
Expiry date	Oct 7, 2019

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.